Reflections on Digital Health Tools for Respiratory Applications

Area of Science:

• Respiratory Medicine
• Digital Health
• Medical Technology

Background:

• A workshop convened by the International Society for Aerosols in Medicine (ISAM) and the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) focused on digital health tools for respiratory therapies.
• The workshop included diverse perspectives from patients, pharmaceutical and technology companies, physicians, and payors.

Purpose of the Study:

• To identify key challenges and opportunities in the development and implementation of digital health tools for respiratory medicine.
• To foster dialogue and collaboration among stakeholders to advance the field.

Main Methods:

• The study is based on presentations from the ISAM and IPAC-RS workshop, audience discussions, and a review of relevant literature.
• Synthesis of diverse stakeholder viewpoints and current research on digital respiratory technologies.

Main Results:

• A significant gap exists between available digital technologies and a clear understanding of the specific problems they should solve in respiratory care.
• Respiratory medicine lacks standardized, easily measurable biomarkers or portable diagnostic tools for complex diseases like asthma.
• Commercial viability is hindered by misaligned stakeholder incentives and a lack of integrated solutions considering patients, physicians, and payors.

Conclusions:

• Successful integration of digital health in respiratory medicine necessitates a needs-driven approach, prioritizing patient and healthcare system priorities over technology-first solutions.
• Addressing the commercialization challenges requires aligning the diverse interests of all stakeholders, including patients, healthcare providers, and payers.
• Ongoing dialogue, information exchange, and collaborative efforts are essential for realizing the full potential of digital tools in respiratory care.